SUSAN GUSTAFSON: Open Payments
NPI 1417393927 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 37 payments from 17 companies in 2025. Trend: 2023 $732 · 2024 $826 · 2025 $1,139
Food & beverage: $1,027Education: $112
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $195 |
| ABBVIE INC. | 3 | $166 |
| Astellas Pharma US Inc | 2 | $129 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Janssen Biotech, Inc. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Celgene Corporation | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Genentech USA, Inc. | 2 | $46 |
Products named: PADCEV, LIBTAYO, KEYTRUDA, RYBREVANT, TAGRISSO, MONJUVI, IBRANCE, OJJAARA.
Industry payments across NY — which companies pay providers there.
